Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan vs Fluid Restriction in Hospitalized Hyponatremia
NCT01227512Phase 3Terminated
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Oct 2010
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolvaptan in hyponatremia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Oct 2010; status: terminated.
02
Drugs
tolvaptan
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT01227512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227512.